BIBLIOGRAFÍA 1.Organización Mundial de la Salud. Concentraciones de hemoglobina para diagnos- ticar la anemia y evaluar su gravedad. OMS, 2011. Disponible en: https://apps.who. int/iris/handle/10665/85842. 2. Muñoz M, Peña-Rosas JP, Robinson S, Milman N, Holzgreve W, Breymann C et al. Patient blood management in obstetrics: management of anaemia and haematinic deficiencies in pregnancy and in the postpartum period: NATA consensus state- ment. Transfus Med. 2018;28(1):22-39. 3. Simon TL, Alverson DC, AuBuchon J, Cooper ES, DeChristopher PJ, Glenn GC et al.Practice parameter for the use of red blood cell transfusions: developed by the Red Blood Cell Administration Practice Guideline Development Task Force of the College of American Pathologists. Arch Pathol Lab Med. 1998;122(2):130-8. 4. I yoke CA, Emegoakor FC, Ezugwu EC, Lawani LO, Ajah LO, Madu JA et al. Effect of treatment with single total-dose intravenous iron versus daily oral iron (III)-hydroxide polymaltose on moderate puerperal iron-deficiency anemia. Ther Clin Risk Manag. 2017;13:647-53. 5. Qassim A, Mol BW, Grivell RM, Grzeskowiak LE. Safety and efficacy of intravenous iron polymaltose, iron sucrose and ferric carboxymaltose in pregnancy: a systemtic review. Aust N Z J Obstet Gynaecol. 2018;58(1):22-39. 6. Auerbach M, Macdougall I.The available intravenous iron formulations: History, efficacy, and toxicology. Hemodial Int. 2017;21(1):83-92. 7. Milman N. Postpartum anemia II: preventions and treatment. Ann Hematol. 2012;91(2):143-54. 8. Holm C, Thomsen LL, Norgaard A, Langhoff-Roos J. Single-dose intravenous iron infusion or oral iron for treatment of fatigue after postpartum haemorrhage: a rando- mized controlled trial.Vox Sang. 2017;112(3):219-28. 58